Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: Influence of type of diabetes, obesity index, and age

Thrombosis Research

Volumn 101, Issue 5, 2001, Pages 367-375

  Vambergue, Anne ^a   Rugeri, Lucia ^a   Gaveriaux, Valérie ^a   Devos, Patrick ^a   Martin, Annie ^b   Fermon, Catherine ^a   Fontaine, Pierre ^a   Jude, Brigitte ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Diabetes; FVII; Obesity; Tissue factor; Tissue Factor Pathway Inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; LIPOPOLYSACCHARIDE; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGE; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ACTIVATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

ADULT; AGE FACTORS; ANTIGENS; APOLIPOPROTEINS; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FACTOR VII; FACTOR XA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MONOCYTES; OBESITY; REFERENCE VALUES; THROMBOPLASTIN;

EID: 0035278831     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00424-2     Document Type: Article

References (29)

1. Diabetes and cardiovascular disease
2. Structural biology of tissue factor the initiator of thrombogenesis in vivo
3. Tissue factor in the pathogenesis of atherosclerosis
4. Cultured normal hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principle site of synthesis
5. Functional significance of the Kunitz-type inhibitor domains of lipoprotein-associated coagulation inhibitor
6. Distinctive features of procoagulant response of monocytes from diabetic patients
7. Blood glucose may condition factor VII levels in diabetic and normal subjects
8. Increased Tissue Factor Pathway Inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus
9. Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity
10. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE
11. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptoxotocin-induced diabetic mice
12. Mechanism on disorders of coagulation and fibrinolysis in diabetes
13. Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with type 2 (non-insulin-dependent) diabetes mellitus
14. Impact of weight loss on Plasminogen Activator Inhibitor (PAI-1), Factor VII, and others hemostatic factors in moderately overweight adults
15. Moderate weight reduction improves red cell aggregation and factor VII activity in overweight subjects
16. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
17. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader
18. An inhibitory monoclonal antibody against human tissue factor
19. Factors of the hemostatic system in diabetic patients. A survey of controlled studies
20. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patient with microalbuminuria
21. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria
22. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men
23. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients
24. Factor VII in non-insulin-dependent diabetic patients with microalbuminuria
25. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus
26. Determination of plasma tissue factor antigen and its clinical significance
27. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus
28. Tissue Factor Pathway Inhibitor activity in patients with IDDM
29. Increased Tissue Factor Pathway Inhibitor activity in IDDM patients with nephropathy